Spinocan Spinal Needle procedure kits: Material Description (Material Number): Spinocan 26 Ga. x 3-1/2 in. (90 mm), Bupivacaine 0.75% with Dextrose 8.25% Tray (Kit) (333201); Spinocan 25 Ga. x 3-1/2 in. (90 mm), Bupivacaine 0.75% with Dextrose 8.25% Tray (Kit) (333211); Spinocan 22 Ga. x 3-1/2 in. (90 mm), Bupivacaine 0.75% with Dextrose 8.25% Tray (Kit) (333231)

Class I

Recalling firm: B Braun Medical Inc
Reason for recall: These procedure kits contain Bupivacaine Hydrochloride in Dextrose Injection, USP. The manufacturer of the Bupivacaine, Huons Co, Ltd., has issued a voluntary recall due to potential quality issues identified during a recent FDA manufacturing facility inspection.
Affected products (lot / model / serial): 1. Material: 333201; UDI-DI Primary/Unit of Use: 4046964179365/4046964179358; Batch Number: 0061976152; 2. Material: 333211; UDI-DI Primary/Unit of Use: 4046964179389/4046964179372; Batch numbers: 0061965729, 0061971323, 0061972572; 3. Material: 333231; UDI-DI Primary/Unit of Use: 4046964179488/4046964179471; Batch Number: 0061978177;
Units affected: 16,080 units
Distribution pattern: US Nationwide distribution.
Firm location: Bethlehem, PA, United States
Recall type: Voluntary: Firm initiated
Product type: Devices
Status: Ongoing
Recall number: Z-2277-2026
Recall initiated: May 6, 2026
FDA classification date: June 3, 2026
FDA report date: June 10, 2026
FDA event ID: 98838
Last updated on HTM Vibe: July 28, 2026